Scientific article
English

Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture

Published inJournal of the American Geriatrics Society, vol. 59, no. 11, p. 2084-2090
Publication date2011
Abstract

To assess the efficacy of once-yearly zoledronic acid (ZOL) 5 mg in increasing bone mineral density (BMD) in men with a recent hip fracture participating in the Health Outcomes and Reduced Incidence with Zoledronic Acid Once- Yearly Recurrent Fracture Trial and to compare the efficacy with that in women from the same study.

Research groups
Citation (ISO format)
BOONEN, Steven et al. Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture. In: Journal of the American Geriatrics Society, 2011, vol. 59, n° 11, p. 2084–2090. doi: 10.1111/j.1532-5415.2011.03666.x
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0002-8614
607views
0downloads

Technical informations

Creation02/12/2013 11:30:00
First validation02/12/2013 11:30:00
Update14/03/2023 20:39:25
Status update14/03/2023 20:39:24
Last indexation30/10/2024 15:07:33
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack